Clinical Research
COVID-19 Update: Our priority is the safety of our research participants and clinical research staff. We will continue to monitor research operations and maintain close communications with research participants that are currently enrolled in active research studies. We will continue to recruit interested participants in studies in order to continue our efforts in advancing knowledge and care for people with complex neuro-inflammatory illnesses. We appreciate your patience during this unprecedented crisis and would like to thank you for your continued support and research participation.
Part of the mission at the Institute for Neuro-Immune Medicine (INIM) is our collaborative relationship between patient care, clinical & laboratory research and systems biology – all under one roof!
There are numerous reasons why people participate in research. Many individuals, whether they are afflicted with an illness or volunteer as a healthy control, participate in order to help contribute to science and help others. In fact, much of our understanding of various illnesses and even health has been improved because of advances in science and technology with the willingness of individuals, like you, that take part in clinical research. Your role as a volunteer in clinical research is crucial in the pursuit for understanding that will help improve the health of future generations. Without the help of patient or healthy volunteers, clinical research studies could not be accomplished.
We are very proud of the clinical research studies that we are currently conducting and pleased to collaborate with institutions such as the Centers for Disease Control and Prevention (CDC), Department of Defense (DoD), Veterans Affairs (VA), National Institutes of Health (NIH), Chronic Fatigue Initiative (CFI) along with other universities and private institutions. We are thankful for individuals like you, whose contribution through participation in our studies and donations have allowed us to make advancements in translational medicine. We are happy to answer your questions and provide further information.